Biologics in rotator cuff repair.

IF 4.9 1区医学 Q1 ORTHOPEDICS

Bone & Joint Journal Pub Date : 2024-09-01 DOI:10.1302/0301-620X.106B9.BJJ-2024-0513.R1

Felix H Savoie Iii, Bela P Delvadia, Jackson P Tate, Julianna E Winter, Garrett H Williams, William F Sherman, Michael J O'Brien

引用次数: 0

Abstract

Rotator cuff tears are common in middle-aged and elderly patients. Despite advances in the surgical repair of rotator cuff tears, the rates of recurrent tear remain high. This may be due to the complexity of the tendons of the rotator cuff, which contributes to an inherently hostile healing environment. During the past 20 years, there has been an increased interest in the use of biologics to complement the healing environment in the shoulder, in order to improve rotator cuff healing and reduce the rate of recurrent tears. The aim of this review is to provide a summary of the current evidence for the use of forms of biological augmentation when repairing rotator cuff tears.

查看原文本刊更多论文

肩袖修复中的生物制剂。

肩袖撕裂常见于中老年患者。尽管肩袖撕裂的手术修复技术不断进步，但肩袖撕裂的复发率仍然很高。这可能是由于肩袖肌腱的复杂性造成了固有的恶劣愈合环境。在过去的 20 年中，人们越来越关注使用生物制剂来补充肩部的愈合环境，以改善肩袖愈合并降低复发性撕裂的发生率。本综述旨在总结目前在修复肩袖撕裂时使用生物制剂的证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone & Joint Journal ORTHOPEDICS-SURGERY

CiteScore

9.40

自引率

10.90%

发文量

318

期刊介绍： We welcome original articles from any part of the world. The papers are assessed by members of the Editorial Board and our international panel of expert reviewers, then either accepted for publication or rejected by the Editor. We receive over 2000 submissions each year and accept about 250 for publication, many after revisions recommended by the reviewers, editors or statistical advisers. A decision usually takes between six and eight weeks. Each paper is assessed by two reviewers with a special interest in the subject covered by the paper, and also by members of the editorial team. Controversial papers will be discussed at a full meeting of the Editorial Board. Publication is between four and six months after acceptance.